trial

Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis

NCTId NCT00465920
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Unknown
Enrollment 42 (estimated)
Sponsored by University of Cologne
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Unknown
Enrollment
42 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2007-05
Primary completion
—
Eligibility
ALL · 14 Years · 18 Years

Interventions & indications

Drugs
modified cognitive behavioural therapy (mCBT)

Sponsors

University of CologneLead Sponsor
Goethe UniversityCollaborator
University Hospital TuebingenCollaborator

Investigators

1
Andreas Bechdolf, PD Dr.Principal Investigator

Sites

1 total
Cologne, Germany

Facts & assertions

3 sourced
Enrollment
42
Phase
PHASE2
Status
UNKNOWN
relationships
The graph out of here
drug
modified cognitive behavioural therapy (mCBT)
drug
lead_sponsor
University of Cologne
company
collaborator
Goethe University
company
University Hospital Tuebingen
company
indication
Schizophreniform Disorder
indication
Psychotic Disorders
indication
Schizoaffective Disorder
indication
investigator
Andreas Bechdolf, PD Dr.
person